about
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.Genetic basis of TNF-α antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysis.Omega-3 fatty acids and inflammatory bowel diseases - a systematic review.Lymphoma in inflammatory bowel disease and treatment decisions.Personalizing therapy for inflammatory bowel diseases.Risk of lymphoma in patients with inflammatory bowel disease.Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.
P2860
Q35572174-F673B2F5-0C82-4688-8AB1-7AD3C050A6ACQ36054928-D2AED9A2-BF52-4FAD-86A8-DA67AC5B34ECQ36586054-BC22DADF-CDBB-4607-80D0-B5BF4E420E76Q38010560-BB60B678-C182-47BD-A940-29C72DCB3F71Q38024070-26172009-6525-4E1E-868E-1D9FDBF36BD5Q38132279-47F889CF-DA01-4712-A6A7-0722B9EB62E4Q41019683-2ED813BE-9AB4-48F0-BEB1-63149931C3E9Q41909607-B83076C2-0E9F-4867-895D-09E303A0CC74Q48194119-9CF4E809-7944-4C95-BAEC-140B98612A41
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety profile of IBD: lymphoma risks.
@en
Safety profile of IBD: lymphoma risks.
@nl
type
label
Safety profile of IBD: lymphoma risks.
@en
Safety profile of IBD: lymphoma risks.
@nl
prefLabel
Safety profile of IBD: lymphoma risks.
@en
Safety profile of IBD: lymphoma risks.
@nl
P1476
Safety profile of IBD: lymphoma risks.
@en
P2093
James D Lewis
Meenakshi Bewtra
P304
P356
10.1016/J.GTC.2009.07.004
P577
2009-12-01T00:00:00Z